BOSTON, LOS ANGELES: PEPTIDE T TRIALS RECRUITING

Phase I trials of Peptide T, a safe but much discussed and controversial anti-HIV treatment possibility, are now seeking recruits at the University of Southern California Medical Center in Los Angeles and the Fenway Community Health Center in Boston. For information about inclusion or exclusion criteria, the Fenway's number is 617/267-7573; for the USC study call 213/226-4643.